Alpha interferon improves survival in patients with metastatic renal carcinoma - Updated results of an MRC randomised controlled trial.

被引:0
|
作者
Oliver, RTD [1 ]
机构
[1] MRC, Clin Trials Unit, Canc Div, Cambridge CB2 2BW, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P161
引用
收藏
页码:69 / 69
页数:1
相关论文
共 50 条
  • [1] Interferon-α and survival in metastatic renal carcinoma:: early results of a randomised controlled trial
    Ritchie, A
    Griffiths, G
    Parmar, M
    Fossa, SD
    Selby, PJ
    Cornbleet, MA
    Sibley, G
    Mead, GM
    Kaye, S
    Owen, JR
    Oliver, RTD
    Smith, PH
    Whelan, P
    Cook, PA
    Fayers, PM
    Cook, P
    Webb, J
    Whitehead, J
    Lamont, A
    LANCET, 1999, 353 (9146): : 14 - 17
  • [2] Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Tomczak, Piotr
    Michaelson, M. Dror
    Bukowski, Ronald M.
    Oudard, Stephane
    Negrier, Sylvie
    Szczylik, Cezary
    Pili, Roberto
    Bjarnason, Georg A.
    Garcia-del-Muro, Xavier
    Sosman, Jeffrey A.
    Solska, Ewa
    Wilding, George
    Thompson, John A.
    Kim, Sindy T.
    Chen, Isan
    Huang, Xin
    Figlin, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (22) : 3584 - 3590
  • [3] Bevacizumab plus interferon-alpha versus interferon-alpha monotherapy in patients with metastatic renal cell carcinoma: Results of overall survival for CALGB 90206
    Rini, B. I.
    Halabi, S.
    Rosenberg, J.
    Stadler, W. M.
    Vaena, D. A.
    Atkins, J. N.
    Picus, J.
    Czaykowski, P.
    Dutcher, J.
    Small, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Bevacizumab plus interferon-alpha versus interferon-alpha monotherapy in patients with metastatic renal cell carcinoma: Results of overall survival for CALGB 90206
    Rini, B. I.
    Halabi, S.
    Rosenberg, J.
    Stadler, W. M.
    Vaena, D. A.
    Atkins, J. N.
    Picus, J.
    Czaykowski, P.
    Dutcher, J.
    Small, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [5] Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma
    Aksoy H.
    Baltaci S.
    Türkölmez K.
    Seçkiner I.
    Bedük Y.
    International Urology and Nephrology, 2001, 33 (3) : 457 - 459
  • [6] Do cytokines improve survival in patients with metastatic renal cell carcinoma (MRCC) of intermediate prognosis? Results of the prospective randomized PERCY Quattro trial.
    Negrier, S
    Perol, D
    Ravaud, A
    Chevreau, C
    Bay, JO
    Delva, R
    Sevin, E
    Caty, A
    Tubiana-Mathieu, N
    Escudier, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1093S - 1093S
  • [7] PROGNOSTIC FACTORS AND SURVIVAL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA TREATED WITH CHEMOTHERAPY OR INTERFERON-ALPHA
    FOSSA, SD
    KRAMAR, A
    DROZ, JP
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1310 - 1314
  • [8] Can exercise influence survival following breast cancer: Results from a randomised, controlled trial.
    Hayes, Sandra Christine
    Steele, Megan
    Spence, Rosa
    Pyke, Christopher
    Saunders, Christobel
    Bashford, John
    Eakin, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Subcutaneous administration of interferon alpha and gamma in patients with metastatic renal cell carcinoma
    Koga, S
    Nishikido, M
    Matsuya, F
    Kanetake, H
    Saito, Y
    ANTICANCER RESEARCH, 1999, 19 (6C) : 5547 - 5550
  • [10] Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma (Reprinted from vol 27, pg 3584, 2009)
    Motzer, Robert J.
    Hutson, Thomas E.
    Tomczak, Piotr
    Michaelson, M. Dror
    Bukowski, Ronald M.
    Oudard, Stephane
    Negrier, Sylvie
    Szczylik, Cezary
    Pili, Roberto
    Bjarnason, Georg A.
    Garcia-del-Muro, Xavier
    Sosman, Jeffrey A.
    Solska, Ewa
    Wilding, George
    Thompson, John A.
    Kim, Sindy T.
    Chen, Isan
    Huang, Xin
    Figlin, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (11) : 1965 - 1971